Sarcopenia is a risk factor for adverse outcome in critically ill patients. Sarcopenia might be estimated from muscle surface measure on tomodensitometry. The purpose of the study is to identify if muscle surfaces measured on thoracic tomodensitometry are associated with mortality in patients with acute respiratory distress syndrome due to SARS-Cov-2.
Study Type
OBSERVATIONAL
Enrollment
200
Demographic data: Age, Sex, weight, height, main history and treatments. \- Biological data: CRP, PCT, albumin, pre-albumin
muscle area calculated on the T7 and T12 thoracic slices
measurement of muscle area at T7 level indexed in cm²/m².
use of CT measurements to discriminate between the 2 groups (deceased versus alive)
Time frame: At hospital admission
Duration of mechanical ventilation
Time frame: within the 28 days
Ventilator free days
Time frame: within the 28 days
number of days in Intensive care unit
Time frame: within the 28 days
number of days in hospital
Time frame: within the 28 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.